WHITEHAWK THERAPEUTICS, INC. (WHWK) Free cash flow 2016–2025
WHITEHAWK THERAPEUTICS, INC. (WHWK) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$98.0MFY2025 · since FY2016: -$137,814 → -$98.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$98.0M | -60.1% |
| FY2024 | -$61.2M | +3.8% |
| FY2023 | -$63.6M | -27.1% |
| FY2022 | -$50.1M | -122.9% |
| FY2021 | -$22.5M | -76.6% |
| FY2020 | -$12.7M | +47.2% |
| FY2019 | -$24.1M | -312.1% |
| FY2018 | -$5.8M | +69.1% |
| FY2017 | -$18.9M | -13608.6% |
| FY2016 | -$137,814 | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More WHWK financial trends
WHWK RevenueWHWK Net incomeWHWK Net marginWHWK Gross profitWHWK Gross marginWHWK Operating incomeWHWK Operating marginWHWK Operating cash flowWHWK Capital expendituresWHWK Return on equityWHWK Stock buybacksWHWK Dividends paidWHWK Total assetsWHWK Total liabilitiesWHWK Shareholders’ equityWHWK overview →